|
|
|
|
|
|
|
|
|
|
Previous: NEUROGENESIS INC, 10SB12G, EX-12, 2000-09-01 |
Next: NEUROGENESIS INC, 10SB12G, EX-14, 2000-09-01 |
| YTD Actual | % | |
| INCOME FROM SALES | ||
| beCALM'd Sales | 66,245 | 54.5 |
| NeuRecover-DA Sales | 31,804 | 26.2 |
| NeuRecover-SA Sales | 13,859 | 11.4 |
| Neuro Slim | 3,281 | 2.7 |
| Ultratrend | 2,467 | 2.0 |
| Inca Gold (60 Capsules) | 2,058 | 1.7 |
| 2 | ** | |
| Booklets- Natural Path | ||
| Manuals | 60 | ** |
| Books & Manuals | 62 | ** |
| S&H; Charged to Customer | 0 | ** |
| Royalty Income | 1,600 | 1.3 |
| Misc. Income | 0 | ** |
| Sale Returns | 0 | ** |
| Total Sales | 121,371 | 100.0 |
| COST OF GOODS SOLD | ||
| BeCALM'd | 15,898 | 13.1 |
| NeuRecover-DA | 11,962 | 9.8 |
| NeuRecover-SA | 3,547 | 2.9 |
| NeuroSlim - 180 Cap | 1,458 | 1.2 |
| Utratrend | 702 | 0.5 |
| Inca Gold 60 Cap | 266 | 0.2 |
| Books and Manuals | 0 | ** |
| Misc. Cost of Goods Sold | 1,884 | 0.5 |
| Total Manufacturing Costs | 35,716 | 29.4 |
| Inventory Loss <Gain> |
(480) |
0.4 |
|
Total Costs of Goods Sold |
35,236 |
29.0 |
|
GROSS MARGIN |
86,140 | 70.9 |
| G & A EXPENSES | ||
| Directors' Fees | 0 | ** |
| Travel & Entertainment | 0 | ** |
| Public Relations | 0 | ** |
| Financing Costs | 0 | ** |
| Patent Expense | 0 | ** |
| Bank Charges | 227 | 0.1 |
| Amort. Expense - Patents | 118 | 0.1 |
| Stock Transfer Exp. | 20 | ** |
| Salaries & C.O.E - G & A | 0 | ** |
| Facilities Expenses | ||
| Office Rental | 9,212 | 7.5 |
| Utilities | 0 | ** |
| Local Telephone | 2,153 | 0.8 |
| Bookkeeping & Acctg Expense | 0 | ** |
| Travel & Entertainment | 75 | ** |
| Office Supplies | 404 | 0.3 |
|
NeuroGenesis, Inc
| ||
|
|
YTD Actual |
% |
|
Copier Expense- |
1,844 |
0.5 |
|
Fax Expense |
18 |
** |
|
Depr Exp Computers |
850 |
0.7 |
|
Depr. Exp. - Furn. & Fixtures |
146 |
0.1 |
|
Postage |
327 |
0.2 |
|
Computer Supplies |
473 |
0.3 |
|
Computer Software |
701 |
0.5 |
|
Audit |
0 |
** |
|
Legal |
3,896 |
3.2 |
|
Insurance Expense |
1,374 |
1.1 |
|
Organizational Expense |
0 |
** |
|
Taxes |
836 |
0.6 |
|
Misc. G & A |
(50) |
** |
|
Total G & A Expenses |
23,606 |
19.4 |
|
|
|
|
|
MARKETING EXPENSES |
|
|
|
Salaries & Cost of Employment |
19,876 |
16.3 |
|
Total Commissions Paid |
21,310 |
17.5 |
|
Credit Card Expense |
1,835 |
1.5 |
|
New Product Research |
0 |
** |
|
Conventions |
0 |
** |
|
Supplies, general |
0 |
** |
|
Sales Aids |
592 |
0.4 |
|
Postage Meter Rent |
0 |
** |
|
Postage |
115 |
** |
|
Samples |
162 |
0.1 |
|
Advertising |
0 |
** |
|
L.D. Telephone |
1,967 |
1.6 |
|
Pager & Cell Phone |
1738 |
1.4 |
|
Travel & Entertainment |
195 |
0.1 |
|
Market Research |
0 |
** |
|
Bad Debt Expense |
495 |
0.4 |
|
Total Marketing Expense |
48,284 |
39.7 |
|
|
|
|
|
RESEARCH & DEVELOPEMENT EXPENSES |
| |
|
Total Salaries |
0 |
** |
|
Clinical Trials |
0 |
** |
|
Misc. |
0 |
** |
|
Total R & D Expense |
0 |
** |
| NeuroGenesis, Inc CONDENSED INCOME STATEMENT Page 3 For the 1 Period Ending June 30, 1999 | ||
|
|
YTD Actual |
% |
| MANUFACTURING & DELIVERY EXPENSE | ||
|
Salaries |
0 |
** |
|
Supplies |
0 |
** |
|
Misc. Mfg Exp. |
0 |
** |
|
Freight OUT |
440 |
0.3 |
|
Freight IN |
1,566 |
1.2 |
|
Prior Year Exp. Paid This Yr |
1,608 |
1.3 |
|
Total Mfg. and Delivery Exp. |
3,614 |
2.9 |
|
|
|
|
|
OTHER EXPENSE AND (INCOME) |
|
|
|
Interest expense (income) |
0 |
** |
|
Multi-Level Marketing |
0 |
** |
|
Treatment Centers |
0 |
** |
|
Other expense (Income) |
684 |
0.5 |
|
Other Income |
0 |
** |
|
Sales discounts |
0 |
** |
|
Miscellaneous |
0 |
** |
|
Total Other Exp. and (inc) |
684 |
0.5 |
|
Net Income From Operations |
9,951 |
8.2 |
|
Assets Acquired From Law Suits |
12,269 |
10.1 |
|
Extraordinary Exp From Law Suits |
0 |
** |
|
NET INCOME |
22,220 |
18.3 |
|
|
|
|
|
|
|
|
|
NeuroGenesis, Inc | ||
|
ASSETS |
|
|
|
CURRENT ASSETS |
|
|
|
Cash |
|
|
|
Wells Fargo checking |
5,070 |
|
|
Bank of America - NGI |
16,240 |
|
|
London 7 Schaeffer Escrow Acct |
0 |
|
|
Petty Cash |
0 |
|
|
Undeposited Cash from AIR |
0 |
|
|
Total Cash |
|
1,309 |
|
|
|
|
|
Accounts Receivable |
|
|
|
Accts Rec -- 3N1 |
19,738 |
|
|
Accts Rec. - NHP |
5,096 |
|
|
Loans to Officers & Directors - AS |
0 |
|
|
AIR Shareholders |
24 |
|
|
Total Accounts Receivable |
|
4,858 |
|
|
|
|
|
Inventory |
|
|
|
beCALM'd Inventory |
5,059 |
|
|
Ultratrend Inventory |
1,299 |
|
|
NuRecover - SA Inventory |
9,414 |
|
|
NeuRecover - DA Inventory |
9,463 |
|
|
NeuroSlim Inventory |
4,602 |
|
|
Inca Gold Inventory |
3,838 |
|
|
Booklets and Manuals |
1,944 |
|
|
Video Tapes |
0 |
|
|
Total Inventory |
|
5,619 |
|
|
|
|
|
Deposits and Prepaid's |
|
0,881 |
|
|
|
________ |
|
Total Current Assets |
|
2,668 |
|
|
|
|
|
FIXED ASSETS |
|
|
|
Furniture & fixtures |
4,922 |
|
|
Accum deprec-Furn & Fixt |
2,241 |
|
|
Computers |
8,499 |
|
|
Accum Depr Computers |
(2,809) |
|
|
Machinery |
1,281 |
|
|
Accum Depr of Machinery. |
(57) |
|
|
Patents |
8,981 |
|
|
Accum Depr on Patents |
(118) |
|
|
Display booths |
3,811 |
|
|
Accum Depr of Display booths |
(3,811) |
|
|
Lease Hold Improvementy |
0 |
|
|
Total Fixed Assets |
|
8,458 |
|
|
|
======= |
|
Total Assets |
|
21,126 |
|
|
|
|
|
NeuroGenesis, Inc | ||
|
|
|
|
|
|
|
|
|
LIABILITIES |
|
|
|
CURRENT LIABILITIES |
|
|
|
Trade Accounts payable |
30,441 |
|
|
Loans From Officers & Directors |
35,618 |
|
|
Commissions Payable |
2,541 |
|
|
Deposits on Sales |
3 |
|
|
Sales tax payable |
815 |
|
|
Withheld Taxes Payable |
(263) |
|
|
Bank Loans |
0 |
|
|
Total Current Liabilities |
|
69,156 |
|
|
|
|
|
EQUITY |
|
|
|
Common Shares @ $0.025 |
43,769 |
|
|
Paid in capital |
1,780,938 |
|
|
Long Term Debt |
138,803 |
|
|
Retained Earnings |
(2,011,540) |
|
|
Total Equity |
|
(48,030) |
|
|
|
======= |
|
TOTAL LIABILITIES |
|
121,126 |
|
|